Stoke Therapeutics names Ian Smith as permanent CEO

Go back to Stoke Therapeutics names Ian Smith as permanent CEO
(NASDAQ: STOK) Delayed: 33.03 --0 (-0%)
Previous Close $33.03    52 Week High
Open $33.03    52 Week Low
Day High $33.03    P/E N/A 
Day Low $33.03    EPS
Volume 342